Advarra Executive and Leadership Team

Gadi Saarony, the Chief Executive Officer at Advarra, directs the overarching strategy and vision for the organization. Saarony guides Advarra's mission to advance clinical research by fostering collaboration among life sciences companies, CROs, research sites, investigators, and academia. This leadership role ensures Advarra's integrated solutions safeguard trial participants, empower clinical sites, and optimize research performance. By focusing on the intersection of safety, technology, and collaboration, Saarony drives the company's commitment to making clinical trials safer, smarter, and faster. The Chief Executive Officer's strategic direction is critical for maintaining Advarra's position at the forefront of the clinical research industry, ensuring continuous innovation and market leadership. Gadi Saarony's executive oversight encompasses all facets of the business, from technological advancements to client partnerships, solidifying Advarra's impact on global health outcomes.

Andrey Zubachev, the Joint Chief Executive Officer at Advarra, shares executive leadership responsibilities, focusing on operational execution and strategic growth initiatives. Zubachev collaborates with Gadi Saarony to advance Advarra's mission of transforming clinical research conduct. This role involves driving the integration of Advarra's trusted review solutions, innovative technologies, and expert consulting services to enhance research performance and compliance. Andrey Zubachev's leadership ensures that Advarra effectively supports life sciences companies, CROs, and research sites in their pursuit of safer, smarter, and faster clinical trials. The Joint Chief Executive Officer's focus on operational excellence and cross-functional synergy is vital for maximizing the impact of Advarra's integrated solutions. By championing collaboration and technological advancement, Andrey Zubachev directly contributes to safeguarding trial participants and empowering research professionals across the industry.

Dwight Van Inwegen, the Chief Financial Officer at Advarra, manages the company's financial strategy and fiscal health. Van Inwegen oversees all financial operations, including budgeting, forecasting, and resource allocation, ensuring Advarra's sustained growth and profitability. This role is critical for supporting the company's mission to advance clinical research through robust financial planning and investment in innovative technologies. The Chief Financial Officer's expertise ensures Advarra can effectively provide integrated solutions that safeguard trial participants and optimize research performance. Dwight Van Inwegen's financial leadership enables Advarra to invest in its people, technology, and client services, reinforcing its commitment to making clinical trials safer, smarter, and faster. Van Inwegen's strategic financial management is fundamental to Advarra's long-term success and its ability to drive positive impact across the life sciences industry.

Scott Uebele, the Chief Operating Officer at Advarra, directs the company's operational infrastructure and service delivery. Uebele oversees the execution of Advarra's integrated solutions, ensuring seamless collaboration between life sciences companies, research sites, and academic institutions. This leadership position is crucial for optimizing research performance and maintaining the highest standards of safety and compliance across all clinical trials. The Chief Operating Officer's responsibilities include enhancing the efficiency of Advarra's review processes and technological platforms, directly supporting the company's goal of making clinical research safer, smarter, and faster. Scott Uebele's operational strategies are designed to empower clinical sites and safeguard trial participants by streamlining workflows and fostering robust communication channels. Uebele's focus on operational excellence underpins Advarra's ability to deliver consistent, high-quality services across the industry.

Michelle Parry, the Chief Human Resources Officer at Advarra, leads the company's talent strategy and organizational development. Parry is responsible for cultivating a high-performance culture that supports Advarra's mission to advance clinical research. This involves attracting, developing, and retaining top talent across all functions, ensuring the team possesses the expertise needed to deliver innovative solutions. The Chief Human Resources Officer's focus on employee engagement and professional growth is essential for empowering clinical sites and safeguarding trial participants. Michelle Parry drives initiatives that foster collaboration, safety, and continuous learning, aligning human capital with Advarra's strategic objectives. Parry's leadership ensures Advarra remains an employer of choice, equipped to meet the evolving demands of the life sciences industry and make clinical trials safer, smarter, and faster.

Allie Rozanski, the Chief Revenue Officer & Client Executive at Advarra, drives revenue growth and manages key client relationships. Rozanski oversees the sales and client success teams, ensuring Advarra's integrated solutions effectively meet the needs of life sciences companies, CROs, and research sites. This dual role is critical for translating market demands into actionable strategies that enhance research performance and client satisfaction. The Chief Revenue Officer & Client Executive's focus on client partnerships and revenue generation directly supports Advarra's mission to make clinical trials safer, smarter, and faster. Allie Rozanski's leadership ensures that Advarra's offerings provide tangible value, safeguarding trial participants and empowering research professionals through collaborative engagement. Rozanski's strategic approach to revenue and client management solidifies Advarra's market position and impact.